Good evening, and welcome to Raymond James Financial's Fiscal Fourth Quarter and Fiscal 2025 Earnings Call. This call is being recorded and will be available for replay on the company's Investor ...

EQB Inc. (TSX: EQB) today announces that its fourth quarter results will be impacted and adjusted for certain notable items ...

NFI Group Inc. (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) and GILLIG LLC, today announced that the companies have formed a 50/50 ...

Century Next Financial Corporation (the “Company”) (OTCQX: CTUY), the holding company of Century Next Bank, with $904.15 ...

NEEDHAM, Mass. and AMESBURY, Mass., Oct. 20, 2025 /PRNewswire/ -- NB Bancorp, Inc. (NASDAQ: NBBK) ("Needham"), the holding company of Needham Bank, and Provident Bancorp ...

Upon consummation of the transaction, Middlefield Bank will be merged with and into Farmers National Bank and Middlefield Bank's branches will become branches of Farmers National Bank. Upon closing, ...

Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and ...

Thomas J. Herzfeld Advisors, Inc., an SEC-registered investment adviser, and Herzfeld Credit Income Fund, Inc. (NASDAQ: HERZ) (the "Fund") today announced ...

Fiera Capital Corporation (TSX: FSZ) (“Fiera Capital” or the “Company”), a leading independent asset management firm, today announced its preliminary estimate of ...

BlackRock Income Trust, Inc. (NYSE: BKT) (the "Fund") today announced the successful completion of its transferable rights offer (the "Offer") which expired on October 20, 2025 (the "Expiration Date") ...

AbbVie (NYSE: ABBV) announced today that it has completed its acquisition of Gilgamesh Pharmaceuticals' lead investigational candidate, bretisilocin.

NORTH CHICAGO, Ill., Oct. 17, 2025 /PRNewswire/-- AbbVie (NYSE: ABBV) announced today that it has completed its acquisition of Gilgamesh Pharmaceuticals' lead investigational candidate, bretisilocin.